FDA Inspection 1210601 — Iovance Biotherapeutics, Inc.
The FDA completed an inspection of Iovance Biotherapeutics, Inc. on July 13, 2023 in San Carlos, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 13, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- San Carlos, CA (United States)
Additional Details
Sponsor, Contract Research Organization